We serve Chemical Name:4-(1,3-dioxolan-2-yl)-2-methylidenebutanal CAS:23985-09-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-(1,3-dioxolan-2-yl)-2-methylidenebutanal
CAS.NO:23985-09-3
Synonyms:1,3-Dioxolane-2-butanal,a-methylene;2-Methylen-5,5-aethylendioxy-pentanal;4-(1,3-dioxolan-2-yl)-2-methylenebutanal
Molecular Formula:C8H12O3
Molecular Weight:156.17900
HS Code:2932999099
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:35.53000
Exact Mass:156.07900
LogP:0.89460
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1,3-Dioxolane-2-butanal,a-methylene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-(1,3-dioxolan-2-yl)-2-methylenebutanal physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-(1,3-dioxolan-2-yl)-2-methylenebutanal Use and application,2-Methylen-5,5-aethylendioxy-pentanal technical grade,usp/ep/jp grade.
Related News: The Company��s immuno-regulatory product candidates include ProTmune, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA. 4-(1,3-dioxolan-2-yl)-2-methylidenebutanal manufacturer Unfortunately, PFAS are considered forever chemicals” because they don’t naturally degrade, Bruton said. Instead, they accumulate in the bodies of humans and animals. It’s believed that every single American has a detectable level of PFAS in their bodies.
Some PFAS chemicals have been shown to be toxic, potentially contributing to high cholesterol levels, low infant birth weights, immune deficiencies and thyroid gland disruptions, according to the EPA.
“The problem with these chemicals is they last a long time in the environment as well as in your body,” said Dr. Maaike van Gerwen, an assistant professor in the Institute of Translational Epidemiology at Mount Sinai in New York City. “We do not know exactly what the harm is of exposure to very low levels of these chemicals over a very long period of time, because these are a relatively new kind of chemical. 4-(1,3-dioxolan-2-yl)-2-methylidenebutanal supplier There is fierce competition for bulk APIs and overcapacity. However, some high-profit, small-scale drugs still have a good market space. 4-(1,3-dioxolan-2-yl)-2-methylidenebutanal vendor Unfortunately, PFAS are considered forever chemicals” because they don’t naturally degrade, Bruton said. Instead, they accumulate in the bodies of humans and animals. It’s believed that every single American has a detectable level of PFAS in their bodies.
Some PFAS chemicals have been shown to be toxic, potentially contributing to high cholesterol levels, low infant birth weights, immune deficiencies and thyroid gland disruptions, according to the EPA.
“The problem with these chemicals is they last a long time in the environment as well as in your body,” said Dr. Maaike van Gerwen, an assistant professor in the Institute of Translational Epidemiology at Mount Sinai in New York City. “We do not know exactly what the harm is of exposure to very low levels of these chemicals over a very long period of time, because these are a relatively new kind of chemical. 4-(1,3-dioxolan-2-yl)-2-methylidenebutanal factory The Company��s immuno-regulatory product candidates include ProTmune, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA.
Some PFAS chemicals have been shown to be toxic, potentially contributing to high cholesterol levels, low infant birth weights, immune deficiencies and thyroid gland disruptions, according to the EPA.
“The problem with these chemicals is they last a long time in the environment as well as in your body,” said Dr. Maaike van Gerwen, an assistant professor in the Institute of Translational Epidemiology at Mount Sinai in New York City. “We do not know exactly what the harm is of exposure to very low levels of these chemicals over a very long period of time, because these are a relatively new kind of chemical. 4-(1,3-dioxolan-2-yl)-2-methylidenebutanal supplier There is fierce competition for bulk APIs and overcapacity. However, some high-profit, small-scale drugs still have a good market space. 4-(1,3-dioxolan-2-yl)-2-methylidenebutanal vendor Unfortunately, PFAS are considered forever chemicals” because they don’t naturally degrade, Bruton said. Instead, they accumulate in the bodies of humans and animals. It’s believed that every single American has a detectable level of PFAS in their bodies.
Some PFAS chemicals have been shown to be toxic, potentially contributing to high cholesterol levels, low infant birth weights, immune deficiencies and thyroid gland disruptions, according to the EPA.
“The problem with these chemicals is they last a long time in the environment as well as in your body,” said Dr. Maaike van Gerwen, an assistant professor in the Institute of Translational Epidemiology at Mount Sinai in New York City. “We do not know exactly what the harm is of exposure to very low levels of these chemicals over a very long period of time, because these are a relatively new kind of chemical. 4-(1,3-dioxolan-2-yl)-2-methylidenebutanal factory The Company��s immuno-regulatory product candidates include ProTmune, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA.
